Search
Now showing items 1-1 of 1
Drug Resistance in Braf-Driven Tumours: The Search for Candidate Mediators and Biomarkers
(2017-04-03)
Activating V600E mutation of the BRAF gene has been identified as being a
biomarker for poor prognosis and overall survival. Targeted therapy for this mutation is
available, nonetheless, melanoma and colon carcinoma with ...